PRESS RELEASE MANDARIN CAPITAL PARTNERS ACQUIRES MIPHARM SPA The goal is to support the international growth of the Company, leveraging Mipharm as a growth platform in the CDMO industry Milan, 06th December 2016 – Mandarin Capital Partners II (MCP II) has successfully acquired a majority stake in the share capital...
- Cassiopea Partners advises Vandewiele in the acquisition of 100% of Savio Group
- Cassiopea Partners advises Wise Equity in the acquisition of a majority stake in Cantiere del Pardo
- Cassiopea Partners advises Antin Infrastructure Partners in the acquisition of a majority stake in Hippocrates Holding
- Cassiopea Partners advised Demenego and its shareholder in the sale of a majority stake to VAM Investments
- Cassiopea Partners advises Armonia in the acquisition of a majority stake of Arrigoni SpA